Impact of exacerbations on lung function, resource utilization, and productivity: results from an observational, prospective study in adults with uncontrolled asthma

被引:5
|
作者
Wisnivesky, Juan [1 ,2 ]
Federmann, Emily [1 ]
Eckert, Laurent [3 ]
West, Erin [4 ]
Amand, Caroline [3 ]
Kamar, Driss [5 ]
Teper, Ariel [6 ]
Khan, Asif H. [3 ]
机构
[1] Icahn Sch Med Mt Sinai, Div Gen Internal Med, Box 1087,One Gustave L Levy Pl, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Div Pulm & Crit Care Med, New York, NY 10029 USA
[3] Sanofi, Chilly Mazarin, France
[4] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland
[5] Ividata Life Sci, Levallois Perret, France
[6] Sanofi, Bridgewater Township, NJ USA
关键词
Forced expiratory volume; symptom exacerbation; airway disease; asthma exacerbations; healthcare resource utilization; DECLINE;
D O I
10.1080/02770903.2022.2130800
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Exacerbations have a major impact on the well-being of patients with uncontrolled asthma. This study evaluated lung function, healthcare resource utilization (HCRU), and productivity loss following asthma exacerbations.Methods: This single-center, observational, prospective cohort study recruited US patients presenting clinically with an acute asthma exacerbation; a reference group without exacerbations was included for comparison. Lung function (forced expiratory volume in 1 second [FEV1]) was collected at baseline, daily during Month 1, and monthly for Months 2-5, and reported as FEV1 percent predicted (FEV(1)pp). HCRU (outpatient visits to a healthcare practitioner, emergency room [ER] visits, and hospitalizations for asthma), oral corticosteroid (OCS) use, and asthma-related work/school absence were collected monthly for 6 months.Results: Overall, 150 patients were recruited (exacerbation: n=102; reference: n=48; mean [SD] age: 42.7 [15.2] and 49.6 [12.4] years; female: 73% and 71%). In both groups, similar trends were observed in FEV1, with significant improvement from baseline to Week 1 (p<0.05), followed by a continuous decline. FEV(1)p was 7.7% lower at baseline and 8.6% lower at Month 5 in the exacerbation group versus the reference group. The exacerbation group had significantly higher rates of OCS prescription during follow-up versus reference group (p=0.04). Over half (52.9%) of patients in the exacerbation group had a recurrent exacerbation during follow-up, increased HCRU (outpatient visits, ER visits, and hospitalizations), and impaired productivity.Conclusion: Although patients with exacerbations had rapid recovery of lung function, this was not maintained and declined faster than in patients without exacerbations. Additionally, patients experienced increased HCRU after exacerbations.
引用
收藏
页码:1072 / 1079
页数:8
相关论文
共 50 条
  • [11] Asthma Exacerbations And Lung Function Decline In A Pooled Analysis Of Adolescents And Adults From Randomized Controlled Trials Of Omalizumab
    Busse, W. W.
    Chipps, B. E.
    Rosen, K.
    Ortiz, B.
    Haselkorn, T.
    Trzaskoma, B. L.
    Lanier, B. Q.
    Szefler, S. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [12] Benralizumab Reduces Exacerbations and Improves Lung Function in Patients From Republic of Korea With Severe, Uncontrolled Asthma: Subgroup Analysis of the SIROCCO Trial
    Park, Hae-Sim
    Lee, Sang Haak
    Werkstrom, Viktoria
    Wu, Yanping
    Zangrilli, James
    Gopalan, Gokul
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB14 - AB14
  • [13] Effects of tezepelumab on asthma exacerbations, type 2 biomarkers, lung function and asthma control in patients with severe, uncontrolled asthma with and without nasal polyps: PATHWAY phase IIb study
    Emson, C.
    Corren, J.
    Salapa, K.
    Hellqvist, A.
    Parnes, J. R.
    Colice, G.
    ALLERGY, 2020, 75 : 19 - 20
  • [14] Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: a prospective observational cohort study
    Simon E Brill
    Anant RC Patel
    Richa Singh
    Alexander J Mackay
    Jeremy S Brown
    John R Hurst
    Respiratory Research, 16
  • [15] Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: a prospective observational cohort study
    Brill, Simon E.
    Patel, Anant R. C.
    Singh, Richa
    Mackay, Alexander J.
    Brown, Jeremy S.
    Hurst, John R.
    RESPIRATORY RESEARCH, 2015, 16
  • [16] Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study
    Hoyte, Flavia
    Martin, Neil
    Kmita, Kamil
    Roseti, Stephanie
    Llanos-Ackert, Jean-Pierre
    Lindsley, Andrew
    Colice, Gene
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB63 - AB63
  • [17] Characteristics of Asthma Exacerbations That Required Hospitalization in Patients with Severe, Uncontrolled Asthma Receiving Tezepelumab Compared with Placebo: Results from the Phase 3 NAVIGATOR Study
    Ambrose, C. S.
    Cook, B.
    Roseti, S. L.
    Gelhorn, H.
    Cutts, K.
    Lindsley, A. W.
    Colice, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [18] Real-life impact of uncontrolled severe asthma on mortality and healthcare use in adolescents and adults: findings from the retrospective, observational RESONANCE study in France
    Roche, Nicolas
    Garcia, Gilles
    de Larrard, Alexandre
    Cancalon, Charlotte
    Benard, Steve
    Perez, Vincent
    Mahieu, Aymeric
    Vieu, Laurine
    Demoly, Pascal
    BMJ OPEN, 2022, 12 (08):
  • [19] Impact of smoking on spondyloarthritis results from a prospective longitudinal observational study (gespic)
    Rudwaleit, M.
    Niewerth, M.
    Listing, J.
    Marker-Hermann, E.
    Zeidler, H.
    Braun, J.
    Sieper, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 540 - 541
  • [20] Impact of mild COVID-19 on balance function in young adults, a prospective observational study
    Agnieszka Guzik
    Andżelina Wolan-Nieroda
    Maciej Kochman
    Lidia Perenc
    Mariusz Drużbicki
    Scientific Reports, 12